Clinical Trial Update: Intranasal Insulin to Prevent Intensive Care Unit Delirium [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluated intranasal insulin for preventing postoperative delirium; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium - Postoperative

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Delirium - Postoperative | Phase 2, Phase 3 | Status: COMPLETED